The 10-year cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes mellitus: an intent-to-treat analysis of diabetes prevention

被引：0
|
作者：
Herman, W. [1 ,2 ]
Edelstein, S. [1 ]
Ratner, R. [3 ]
Montez, M. [4 ]
Ackermann, R. [5 ]
Orchard, T. [6 ]
Foulkes, M. [1 ]
Zhang, P. [7 ]
Saudek, C. [8 ]
Brown, M.
机构：
[1] George Washington Univ, Ctr Biostat, Rockville, MD USA
[2] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[3] Medstar Hlth Res Inst, Washington, DC USA
[4] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[5] Indiana Univ Sch Med, Indianapolis, IN USA
[6] Univ Pittsburgh, Pittsburgh, PA USA
[7] Ctr Dis Control, Atlanta, GA 30333 USA
[8] Johns Hopkins Univ, Baltimore, MD USA
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
904
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [21] Primary prevention of type 2 diabetes by lifestyle intervention in primary care setting
    Umpierrez, G. E.
    Pasquel, Francisco J.
    REVISTA CLINICA ESPANOLA, 2014, 214 (02): : 79 - 82
  • [22] Cost-effectiveness analysis of a carbose in the prevention of type 2 diabetes in South Korea
    JongMann, K.
    Clegg, J. P.
    Chang, K.
    JuYeol, P.
    Wittrup-Jensen, K. U.
    Valentine, W. J.
    VALUE IN HEALTH, 2007, 10 (06) : A262 - A262
  • [23] The impact of Type 2 diabetes prevention programmes based on risk-identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis
    Breeze, P. R.
    Thomas, C.
    Squires, H.
    Brennan, A.
    Greaves, C.
    Diggle, P. J.
    Brunner, E.
    Tabak, A.
    Preston, L.
    Chilcott, J.
    DIABETIC MEDICINE, 2017, 34 (05) : 632 - 640
  • [24] Selecting Intervention Population for Lifestyle Program for Type 2 Diabetes Prevention (LPT2DP): A Cost-Effectiveness Perspective
    Park, Joohyun
    Zhang, Ping
    Shao, Hui
    Laxy, Michael
    DIABETES, 2021, 70
  • [25] Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes
    Li, Te
    Wan, Xu
    Ma, Jin
    Wu, Bin
    ADVANCES IN THERAPY, 2018, 35 (12) : 2214 - 2223
  • [26] Incremental Cost-Effectiveness Ratios (ICERs) and Revised Metformin Cost-Effectiveness Conclusions in the Diabetes Prevention Program/ Diabetes Prevention Program Outcomes Study
    Alolayan, Sultan
    Eguale, Tewodros
    Segal, Alissa R.
    Doucette, Joanne
    Rittenhouse, Brian E.
    AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2025,
  • [27] Cost-Effectiveness of Primary Prevention with Statin Treatment for Chinese Patients with Type 2 Diabetes
    Te Li
    Xu Wan
    Jin Ma
    Bin Wu
    Advances in Therapy, 2018, 35 : 2214 - 2223
  • [28] Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease
    Kohli-Lynch, Ciaran N.
    Lewsey, James
    Boyd, Kathleen A.
    French, Dustin D.
    Jordan, Neil
    Moran, Andrew E.
    Sattar, Naveed
    Preiss, David
    Briggs, Andrew H.
    CIRCULATION, 2022, 145 (17) : 1312 - 1323
  • [29] Cost and cost-effectiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: A systematic review
    Rinaldi, Giulia
    Hijazi, Alexa
    Haghparast-Bidgoli, Hassan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162
  • [30] Prevention of type 2 diabetes mellitus. Cost-utility of lifestyle modification compared to metformin treatment
    Hoffmann, B
    Gericke, CA
    MEDIZINISCHE KLINIK, 2005, 100 (10) : 686 - 688
12345